000			02693cam a2200289 4500500
005			20250121155346.0
041			_afre
042			_adc
100	1	0	_aStefanou, Garyfallia _eauthor
700	1	0	_a Gregoriou, Stamatis _eauthor
700	1	0	_a Kontodimas, Stathis _eauthor
700	1	0	_a Sfaelos, Kostas _eauthor
700	1	0	_a Vakirlis, Efstratios _eauthor
700	1	0	_a Kourlaba, Georgia _eauthor
245	0	0	_aPrevalence of adult self-reported atopic dermatitis in Greece: results from a nationwide survey
260			_c2022.
500			_a27
520			_aBackgroundAtopic dermatitis (AD) is a common chronic inflammatory skin disorder. In Greece, there is a lack of data on AD epidemiology.ObjectivesThe objective of the present study was to estimate the self-reported prevalence of AD and the prevalence of moderate/severe AD in the adult population in Greece.Materials & MethodsA nationwide cross-sectional survey with a structured questionnaire was conducted, between June 17th, 2021 and July 12th, 2021, using Computer Assisted Telephone Interviewing (CATI) and Computer Assisted web Interviewing (CAWI) data collection methods. Several different self-reported AD definitions, as extracted from the literature, were used. Self-reported moderate/severe atopic dermatitis was estimated using the Patient Oriented Eczema Measure (POEM).ResultsMore than 30,500 persons were invited to participate; among them, 3,001 were recruited for the survey. The 12-month self-reported AD prevalence in Greece ranged from 1.7% to 6.4%, while lifetime prevalence reached 11.4%. At least half of the responders who identified with AD during the last 12 months had moderate to very severe eczema. The multivariate analysis confirmed that age, atopy-related comorbidities (asthma, allergies, and rhinitis), a family history of AD, rhinitis, and asthma were factors that are independently associated with AD, irrespective of the definition used.ConclusionThe 12-month and lifetime prevalence of AD in adults in Greece ranges from 1.7% to 6.4% and 3.7% to 11.4%, respectively. At least half of the adults with AD suffer from moderate-to-severe disease. Our study is a first step in understanding AD epidemiology in Greece and may provide useful insights for healthcare decision makers.
690			_aatopic dermatitis
690			_asurvey
690			_aself-reported prevalence
690			_aatopic dermatitis
690			_asurvey
690			_aself-reported prevalence
786	0		_nEuropean Journal of Dermatology | 32 | 5 | 2022-09-01 | p. 597-606 | 1167-1122
856	4	1	_uhttps://shs.cairn.info/revue-european-journal-of-dermatology-2022-5-page-597?lang=en&redirect-ssocas=7080
999			_c604540 _d604540